Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

China · Delayed Price · Currency is CNY

20.73

-0.14 (-0.67%)

Aug 26, 2026, 3:04 PM CST

26.09% (1Y)

Market Cap	23.49B +24.4%
Revenue (ttm)	9.16B -17.0%
Net Income	850.01M -12.3%
EPS	0.74 -11.9%
Shares Out	1.13B
PE Ratio	28.30
Forward PE	16.30
Dividend	0.48 (2.26%)
Ex-Dividend Date	Apr 29, 2026

Volume	12,551,154
Open	20.81
Previous Close	20.87
Day's Range	20.38 - 21.18
52-Week Range	14.89 - 24.85
Beta	0.21
Analysts	Strong Buy
Price Target	24.07 (+16.11%)
Earnings Date	Aug 20, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects;... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1989

Employees 6,787

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000739

Full Company Profile

Financial Performance

In 2025, SHE:000739's revenue was 9.78 billion, a decrease of -18.62% compared to the previous year's 12.02 billion. Earnings were 890.68 million, a decrease of -13.62%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 000739 stock is "Strong Buy." The 12-month stock price target is ¥24.07, which is an increase of 16.11% from the latest price.

Price Target

¥24.07

(16.11% upside)

Analyst Consensus: Strong Buy

Stock Forecasts